ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,489Medicare Part D Prescriptions Filled, Including Refills

Rank: 34 out of 387

$943K Total Retail Price of All Prescriptions

Rank: 36 out of 387

565 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
20% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oklahoma
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 565 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

16% of this provider’s 565 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

2% of this provider’s 13,221 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
SIMVASTATIN 657 603 1 5
OMEPRAZOLE 584 489 2 4
HYDROCODONE-ACETAMINOPHEN 539 395 S3 3 1
FUROSEMIDE 455 417 4 7
LEVOTHYROXINE SODIUM 448 421 5 2
LISINOPRIL 440 391 6 3
AMLODIPINE BESYLATE 433 385 7 6
ATORVASTATIN CALCIUM 401 376 8 13
SERTRALINE HCL 379 298 9 23
LOSARTAN POTASSIUM 369 353 10 24
CARVEDILOL 359 319 11 21
HYDROCHLOROTHIAZIDE 334 285 12 12
ZOLPIDEM TARTRATE 291 216 13 16
MELOXICAM 262 217 14 22
GABAPENTIN 232 176 15 10
WARFARIN SODIUM 225 191 16 17
METFORMIN HCL 204 152 17 8
METOPROLOL SUCCINATE 201 195 18 18
METOPROLOL TARTRATE 196 169 19 11
CRESTOR 190 176 20 34
POTASSIUM CHLORIDE 177 173 21 9
FLUTICASONE PROPIONATE 150 142 22 29
ALLOPURINOL 148 137 23 28
TRAZODONE HCL 145 139 24 37
GLIMEPIRIDE 137 119 25 50
ADVAIR DISKUS 136 99 26 41
PRAVASTATIN SODIUM 134 118 27 15
ISOSORBIDE MONONITRATE ER 134 129 27 59
DONEPEZIL HCL 129 127 29 27
DIOVAN 128 114 30 33
PREDNISONE 126 120 31 43
DIGOXIN 120 107 32 40
CELEBREX 120 101 32 72
SPIRIVA 118 99 34 61
TRAMADOL HCL 118 91 34 14
KLOR-CON 8 115 85 36 146
NEXIUM 114 110 37 26
LEVOXYL 111 99 38 216
CYCLOBENZAPRINE HCL 107 82 R 39 42
CLOPIDOGREL 99 96 40 25
ESCITALOPRAM OXALATE 97 57 41 73
PAROXETINE HCL 92 77 42 52
INSULIN SYRINGE 91 83 43 151
RANITIDINE HCL 88 82 44 45
CITALOPRAM HBR 88 86 44 19
CEFDINIR 87 73 46 163
SUCRALFATE 87 68 46 128
SPIRONOLACTONE 87 84 46 67
LIPITOR 84 74 49 103
QUINAPRIL HCL 84 51 49 174
PROAIR HFA 81 72 51 47
DOXYCYCLINE HYCLATE 79 71 52 114
CLONIDINE HCL 76 66 53 38
CYMBALTA 75 75 54 44
EVISTA 74 74 55 111
ENALAPRIL MALEATE 69 62 56 69
PLAVIX 65 63 57 39
CEFUROXIME 62 58 58 178
HYDRALAZINE HCL 60 47 59 94
ENDOCET 58 43 S2 60 147
COLESTIPOL HCL 55 46 61 229
METHYLPREDNISOLONE 53 52 62 101
BUSPIRONE HCL 52 36 63 121
JANUVIA 52 44 63 60
PRAMIPEXOLE DIHYDROCHLORIDE 51 39 65 166
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 28, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.